| | | 65052 | | 30.07.2014 | | MSD Merck Sharp & Dohme AG | | | | | | | | | | | | | 07.06.20. | | | | 07.06.20. | | IP |
| | Seq.-No. | Product | Description | Galenic form | ATC-classification | |
|---|
| 01 | Janumet XR 50 mg/500 mg | Filmtabletten | Coated tablets (Metformin Hydrochloride 500 mg, Sitagliptine Phosphate Monohydrate 64.25 mg) | A10BD07 | CI | | 02 | Janumet XR 50 mg/1000 mg | Filmtabletten | Coated tablets (Metformin Hydrochloride 1000 mg, Sitagliptine Phosphate Monohydrate 64.25 mg) | A10BD07 | CI | | 03 | Janumet XR 100 mg/1000 mg | Filmtabletten | Coated tablets (Metformin Hydrochloride 1000 mg, Sitagliptine Phosphate Monohydrate 128.5 mg) | A10BD07 | CI |
|
|
